About this journal
Aims and scope
Nanotoxicology publishes peer-reviewed research relating to the hazards, exposure, and risks associated with nano-structured materials during their life cycle.
The journal primarily covers research on any material with at least one dimension in the nanometer size range (1-100nm). This includes nanoparticles, nanomaterials (including high aspect ratio nanomaterials (HARN) and fibres), nanomedicines, nano-surfaces of larger materials, nanocomposites, and advanced materials. Such materials may be used in a range of consumer products (e.g. paints, cosmetics, electronics, textiles, packaging), generated for intentional delivery into the body (e.g. food, medicines, diagnostics, medical devices), or designed for environmental applications (such as remediation of contaminated sites). We will consider research on different sources (e.g. natural, anthropogenic, engineered) of all of these materials, as well as studies which focus on assessment of the hazards, exposure and risks of air pollution particles (e.g. PM 10, PM 2.5), micro and nanoplastics, and occupational dusts. Articles which focus on single or agglomerated/aggregated particles can be submitted to the journal. We will also publish papers on studies related to solid phase materials, aerosols or colloids if humans are potentially exposed or if they might be released into the environment.
We are particularly interested in studies which have assessed the hazards of nanomaterials to human health and the environment using in chemico, in silico, in vitro, and in vivo models as well as epidemiological studies and encourage the submission of articles which have investigated the mechanism(s) of toxicity.
Studies that support understanding of environmental and human exposure and risk assessment are within the scope of the journal. Furthermore, articles which focus on legislation and regulation are strongly welcomed.
Research articles relevant to the area of nanomedicine will be considered but there must be a strong safety or toxicology component. More specifically, the manuscript should not be focussed solely on investigating clinical effectiveness of the nanomedicine but must present toxicology data from a relevant model and assess the toxicity using appropriate endpoints (e.g. viability assays to assess cytotoxicity in vitro alone is not sufficient).
It is essential that the physicochemical properties of ‘as produced/supplied’ materials as well as dispersions of the materials in relevant biological media are well characterized. We encourage the use of standard or reference materials such as those supplied from the US National Institute of Standards or those selected by the OECD Working Party on Manufactured Nanomaterials. We do not publish papers on nanomaterials produced by new principles of synthesis if toxicological effects are not analysed in parallel with well established reference or benchmark materials.
The journal welcomes original basic and clinical research articles, review articles including meta-analyses, short communications, study protocols, case reports, clinical practice papers, letters to the Editor, inaugural lectures, conference abstracts and book reviews.
If you have suggestions for special issues of Nanotoxicology then please contact the editors.
Nanotoxicology operates a single-anonymized peer review policy. Authors can choose to publish gold open access in this journal.
Journal metrics
Usage
- 120K annual downloads/views
Citation metrics
- 3.6 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 4.6 (2023) 5 year IF
- 10.1 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.743 (2023) SNIP
- 0.821 (2023) SJR
Speed/acceptance
- 5 days avg. from submission to first decision
- 40 days avg. from submission to first post-review decision
- 15 days avg. from acceptance to online publication
- 21% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor in Chief:
Prof. Håkan Wallin - National Institute of Occupational Health (STAMI), Oslo, Norway
Deputy Editor:
Prof. Helinor Johnston - Heriot-Watt University, Edinburgh, Scotland, UK
Associate Editors:
Prof. Anders Baun - Technical University of Denmark, Lyngby, Denmark
Prof. Wan-Seob Cho - Dong-A University, Busan, South Korea
Dr. Alison Elder - University of Rochester, Rochester, NY, USA
Prof. Peter Hoet - Catholic University of Leuven, Leuven, Belgium
Dr. Dana Kühnel - Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany
Prof. Willie Peijnenburg - Leiden University, Leiden, Netherlands
Dr. Tobias Stöger - Helmholtz Zentrum München, Munich, Germany
Prof. Vicki Stone - Heriot-Watt University, Edinburgh, Scotland, UK
Dr. Mark Wiesner - Duke University, Durham, NC, USA
Prof. Tian Xia - University of California Los Angeles, CA, USA
Editorial Board:
Prof. Marc Benedetti - Université Denis Diderot, Paris, France
Dr. Pratim Biswas - Washington University in St Louis, MO, USA
Dr. James Bonner - North Carolina State University, Raleigh, NC, USA
Dr. Flemming Cassee - National Institute for Public Health and the Environment, Bilthoven, Netherlands
Prof. Chunying Chen - National Center for Nanoscience and Technology, Beijing, China
Dr. Fanqing Fran Chen - Lawrence Berkeley National Laboratory, Berkeley, USA
Dr. Alok Dhawan - CSIR-Indian Institute of Toxicology Research Vishvigyan Bhawan, Lucknow. Uttar Pradesh, India
Prof. Greg Goss - University of Alberta, Canada
Prof. Andrij Holian - University of Montana, Missoula, USA
Dr Saber Hussain, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, USA
Dr. Wim de Jong – RVIM, Netherlands
Dr. Wolfgang Kreyling - Institute for Inhalation Biology, Germany
Prof. Steffen Loft - University of Copenhagen, Copenhagen, Denmark
Prof. Lutz Mädler - University of Bremen, Bremen, Germany
Dr. Andrew Maynard - School for the Future of Innovation in Society, Arizona State University, Tempe, AZ, USA
Dr. Nancy Monteiro-Riviere - Kansas State University and North Carolina State University, Raleigh, NC, USA
Dr. Yasuo Morimoto - University of Occupational and Environmental Health, Kitakyushu, Japan
Dr. Timothy Nurkiewicz - West Virginia University, Morgantown, WV, USA
Prof. Günter Oberdörster - University of Rochester, Rochester, NY, USA
Dr. Galya Orr - Pacific Northwest Laboratory, WA, USA
Prof. Wolfgang J. Parak - University of Hamburg, Germany
Dr. Jessica Ponti – Joint Research Centre, Italy
Dr. Michael Riediker - Swiss Centre for ccupational and Environmental Health (SCOEH), Winterthur, Switzerland
Dr. Barbara Rothen-Rutishauser - Université de Fribourg, Marly, Switzerland
Dr. Enrico Sabbioni - University of Chieti, Italy
Dr. Christie Sayes - Baylor University, Waco, 76798 TX, USA
Dr. Lang Tran - Institute of Occupational Medicine, perivale, Middlesex, UK
Dr. Peter Wick - Empa, St Gallen, Switzerland
Abstracting and indexing
Nanotoxicology is included in the following abstracting and indexing services:
Biochemistry & Biophysics Citation Index; Biological Abstracts; BIOSIS Previews; Current Contents/Agriculture, Biology, and Environmental Sciences; Current Contents/Life Sciences; Current Contents/Social and Behavioral Sciences; Journal Citation Reports/Science Edition.
Open access
Nanotoxicology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
10 issues per year
Advertising information
Would you like to advertise in Nanotoxicology?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Nanotoxicology.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors